Treatment duration of febrile urinary tract infections

Current Infectious Disease Reports

Volumn 13, Issue 6, 2011, Pages 571-578

  Van Der Starre, Willize E ^a   Van Dissel, Jaap T ^a   Van Nieuwkoop, Cees ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

Author keywords

Acute pyelonephritis; Antibiotics; Complicated urinary tract infection; Febrile urinary tract infections; Fluoroquinolones; Prostatitis

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFADROXIL; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; LOMEFLOXACIN; NORFLOXACIN; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE PYELONEPHRITIS; BACTEREMIA; CATHETER INFECTION; COMORBIDITY; CYSTITIS; DIABETES MELLITUS; DOSAGE SCHEDULE COMPARISON; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; ELDERLY CARE; FEBRILE URINARY TRACT INFECTION; HUMAN; LOW DRUG DOSE; PATIENT CARE; PRACTICE GUIDELINE; PYELONEPHRITIS; PYONEPHROSIS; REVIEW; SEX DIFFERENCE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; URINARY TRACT DISEASE; URINARY TRACT INFECTION;

EID: 81155130885     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-011-0211-y     Document Type: Review

References (36)

1. WE Stamm TM Hooton 1993 Management of urinary tract infections in adults N Engl J Med 329 1328 1334 8413414 10.1056/NEJM199310283291808 1:STN:280:DyaK2c%2FhvFGluw%3D%3D (Pubitemid 23317334)
2. KG Naber 1999 Experience with the new guidelines on evaluation of new anti-infective drugs for the treatment of urinary tract infections Int J Antimicrob Agents 11 189 196 10394969 10.1016/S0924-8579(99)00014-X 1:CAS:528:DyaK1MXjslGitr4%3D (Pubitemid 29231958)
3. JN Krieger L Nyberg Jr JC Nickel 1999 NIH consensus definition and classification of prostatitis JAMA 282 236 237 10422990 10.1001/jama.282.3.236 1:STN:280:DyaK1MzkvFymsQ%3D%3D (Pubitemid 29343164)
4. K Gupta TM Hooton KG Naber, et al. 2011 International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases Clin Infect Dis 52 e103 e120 21292654 10.1093/cid/ciq257 This recently updated guideline gives an overview of treatment recommendations in premenopausal, otherwise healthy women with febrile UTI
5. CM Kunin 2003 Definition of acute pyelonephritis vs the urosepsis syndrome Arch Intern Med 163 2393 2394 14581259 10.1001/archinte.163.19.2393-b (Pubitemid 37310201)
6. JN Rubenstein AJ Schaeffer 2003 Managing complicated urinary tract infections: the urologic view Infect Dis Clin North Am 17 333 351 12848473 10.1016/S0891-5520(03)00012-6 (Pubitemid 36760186)
7. K Ramakrishnan DC Scheid 2005 Diagnosis and management of acute pyelonephritis in adults Am Fam Physician 71 933 942 15768623 (Pubitemid 40321958)
8. LE Nicolle 2008 Short-term therapy for urinary tract infection: success and failure Int J Antimicrob Agents 31 40 45 10.1016/j.ijantimicag.2007.07.040
9. ACOG Practice Bulletin No. 91 2008 Treatment of urinary tract infections in nonpregnant women Obstet Gynecol 111 785 794 10.1097/AOG.0b013e318169f6ef (Pubitemid 351654092)
10. • European Association of Urology: guidelines on urological infections. Available at www.uroweb.org. Accessed 15-4-2011. This guideline outlines concisely and to-the-point the current recommendations for treatment of febrile UTI.
11. NS Patel 2007 Fluoroquinolone use is the predominant risk factor for the development of a new strain of clostridium difficile-associated disease BJU Int 99 1333 1334 17233799 10.1111/j.1464-410X.2006.06741.x (Pubitemid 47164788)
12. SV Kazakova K Ware B Baughman, et al. 2006 A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile Arch Intern Med 166 2518 2524 17159019 10.1001/archinte.166.22.2518 (Pubitemid 44913237)
13. VG Loo L Poirier MA Miller, et al. 2005 A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality N Engl J Med 353 2442 2449 16322602 10.1056/NEJMoa051639 1:CAS:528:DC%2BD2MXhtlShurvK (Pubitemid 41770165)
14. B Foxman M Ki P Brown 2007 Antibiotic resistance and pyelonephritis Clin Infect Dis 45 281 283 17599304 10.1086/519267 (Pubitemid 47101022)
15. WE Stamm M McKevitt GW Counts 1987 Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. A randomized trial Ann Intern Med 106 341 345 3492950 1:STN:280: DyaL2s7is1WgtQ%3D%3D (Pubitemid 17029482)
16. BA Cunha 1989 Nitrofurantoin: an update Obstet Gynecol Surv 44 399 406 2657522 10.1097/00006254-198905000-00034 1:STN:280:DyaL1M3mt12rug%3D%3D (Pubitemid 19132485)
17. DA Talan WE Stamm TM Hooton, et al. 2000 Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial JAMA 283 1583 1590 10735395 10.1001/jama.283.12.1583 1:CAS:528:DC%2BD3cXisVehsr4%3D (Pubitemid 30161514)
18. HA Klausner P Brown J Peterson, et al. 2007 A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis Curr Med Res Opin 23 2637 2645 17880755 10.1185/030079907X233340 1:CAS:528:DC%2BD2sXhsVyjtrbP (Pubitemid 350146402)
19. J Peterson S Kaul M Khashab, et al. 2008 A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis Urology 71 17 22 18242357 10.1016/j.urology.2007.09.002 (Pubitemid 351173271)
20. S Cronberg S Banke B Bergman, et al. 2001 Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime Scand J Infect Dis 33 339 343 11440218 10.1080/003655401750173922 1:CAS:528:DC%2BD3MXltFeksrc%3D (Pubitemid 32573982)
21. GA Richard IN Klimberg CL Fowler, et al. 1998 Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis Urology 52 51 55 9671870 10.1016/S0090-4295(98)00160-5 1:STN:280:DyaK1czjsFGqsw%3D%3D (Pubitemid 28317929)
22. H Arslan OK Azap O Ergonul, et al. 2005 Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey J Antimicrob Chemother 56 914 918 16174685 10.1093/jac/dki344 1:CAS:528:DC%2BD2MXhtFCjtLbJ (Pubitemid 41631917)
23. S Chaniotaki P Giakouppi LS Tzouvelekis, et al. 2004 Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece Clin Microbiol Infect 10 75 78 14706091 10.1111/j.1469-0691.2004. 00807.x 1:CAS:528:DC%2BD2cXhsVGntrw%3D (Pubitemid 38128596)
24. T Sandberg G Englund K Lincoln, et al. 1990 Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis Eur J Clin Microbiol Infect Dis 9 317 323 2197091 10.1007/BF01973737 1:STN:280:DyaK3czitlSisA%3D%3D (Pubitemid 20175565)
25. TM Hooton D Scholes K Gupta, et al. 2005 Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial JAMA 293 949 955 15728165 10.1001/jama.293.8.949 1:CAS:528: DC%2BD2MXhsFCgtLw%3D (Pubitemid 40271126)
26. KAM van Haaren HS Visser S van Vliet, et al. 2005 NHG-Standaard Urineweginfecties: tweede herziening [Guideline of the Dutch College of General Practitioners on urinary tract infections: second revision] Huisarts Wet 48 341 352 10.1007/BF03084253
27. C van Nieuwkoop JW Van't Wout WJ Assendelft, et al. 2009 Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days) BMC Infect Dis 9 131 19691829 10.1186/1471-2334-9-131
28. LH Vorland K Carlson O Aalen 1985 An epidemiological survey of urinary tract infections among outpatients in Northern Norway Scand J Infect Dis 17 277 283 4059868 1:STN:280:DyaL28%2FksVeksg%3D%3D (Pubitemid 15236704)
29. P Ulleryd B Zackrisson G Aus, et al. 1999 Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography BJU Int 84 470 474 10468764 10.1046/j.1464-410x.1999.00164.x 1:STN:280:DyaK1MzpvV2jtQ%3D%3D (Pubitemid 29419417)
30. FM Wagenlehner KG Naber 2005 Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men Curr Infect Dis Rep 7 9 16 15610666 10.1007/s11908-005-0018-9 (Pubitemid 40220524)
31. BA Lipsky 1999 Prostatitis and urinary tract infection in men: what's new; what's true? Am J Med 106 327 334 10190383 10.1016/S0002-9343(99)00017-0 1:STN:280:DyaK1M3gsVKmug%3D%3D (Pubitemid 29153412)
32. P Ulleryd T Sandberg 2003 Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up Scand J Infect Dis 35 34 39 12685882 10.1080/0036554021000026988 (Pubitemid 36336365)
33. G Mombelli R Pezzoli G Pinoja-Lutz, et al. 1999 Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial Arch Intern Med 159 53 58 9892331 10.1001/archinte.159.1.53 1:STN:280: DyaK1M7gslenuw%3D%3D (Pubitemid 29044120)
34. C van Nieuwkoop JW Van't Wout IC Spelt, et al. 2010 Prospective cohort study of acute pyelonephritis in adults: Safety of triage towards home based oral antimicrobial treatment J Infect 60 114 21 19945482 10.1016/j.jinf.2009.11. 008 This observational study showed that a 2-week regimen of an oral fluoroquinolone might be sufficient, even in the elderly and patients with comorbidities
35. LE Nicolle 1994 Urinary tract infection in the elderly J Antimicrob Chemother 33 Suppl A 99 109 7928842 (Pubitemid 24201988)
36. GD Fang C Brennen M Wagener, et al. 1991 Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study Antimicrob Agents Chemother 35 1849 1855 1952856 1:STN:280:DyaK38%2FmtV2ntw%3D%3D